Company research
Semler Scientific, Inc.
CIK 1554859Updated Oct 6, 2026
Historical securities (1)
SMLR · NASDAQ · equity · closed Jan 16, 2026SMLR price & chart
This listing closed Jan 16, 2026. Live provider charts are shown only for current listings.
About the company
Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. Additional information about Semler Scientific can be found at www.semlerscientific.com. Semler Scientific intends to use its Bitcoin dashboard and its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Semler Scien…
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 596,677,000Source | 92,194,000Source | 79,443,000Source | 522,597,000Source | 84,786,000Source | 75,462,000Source | 293,445,000Source | 83,856,000Source | 239,828,000Source | 78,065,000Source | 62,693,000Source | 50,672,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,176,000Source | 6,568,000Source | 37,497,000Source | 13,482,000Source | 7,332,000Source | 39,495,000Source | 9,737,000Source | 62,754,000Source | 8,819,000Source | 57,200,000Source | 23,014,000Source | 37,323,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,558,000Source | 6,667,000Source | 5,966,000Source | 2,831,000Source | 7,470,000Source | 6,032,000Source | 3,139,000Source | 6,132,000Source | 4,378,000Source | 6,125,000Source | 3,884,000Source | 3,619,000Source |
| Inventory, NetUSD | 485,000Source | 380,000Source | 439,000Source | 558,000Source | 385,000Source | 476,000Source | 370,000Source | 408,000Source | 358,000Source | 445,000Source | 469,000Source | 550,000Source |
| Assets, CurrentUSD | 53,506,000Source | 21,494,000Source | 64,378,000Source | 21,898,000Source | 23,690,000Source | 60,751,000Source | 18,452,000Source | 71,905,000Source | 22,688,000Source | 65,944,000Source | 48,908,000Source | 45,536,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,954,000Source | 1,646,000Source | 1,946,000Source | 4,623,000Source | 2,271,000Source | 2,418,000Source | 4,822,000Source | 2,479,000Source | 2,900,000Source | 2,042,000Source | 1,468,000Source | 4,044,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | 87,000Source | 171,000Source | 22,000Source | 108,000Source | 192,000Source | 44,000Source | 129,000Source | 65,000Source | 150,000Source | 233,000Source | 314,000Source |
| Other Assets, NoncurrentUSD | 1,000Source | 106,000Source | 2,744,000Source | 23,000Source | 127,000Source | 2,736,000Source | 64,000Source | 249,000Source | 85,000Source | 270,000Source | 2,842,000Source | 332,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 15,000Source | 7,000Source | 7,000Source | 14,000Source | 7,000Source | 7,000Source | 10,000Source | 7,000Source | 9,000Source | 7,000Source | 7,000Source | 7,000Source |
| Additional Paid in CapitalUSD | 339,900,000Source | 13,852,000Source | 15,184,000Source | 280,463,000Source | 12,504,000Source | 15,188,000Source | 125,673,000Source | 12,023,000Source | 130,039,000Source | 11,985,000Source | 16,449,000Source | 20,645,000Source |
| Retained Earnings (Accumulated Deficit)USD | 119,834,000Source | 71,496,000Source | 55,582,000Source | 102,932,000Source | 65,887,000Source | 50,068,000Source | 36,000,000Source | 65,876,000Source | 100,702,000Source | 59,803,000Source | 39,220,000Source | 24,895,000Source |
| Stockholders' Equity Attributable to ParentUSD | 459,749,000Source | 85,355,000Source | 70,773,000Source | 383,409,000Source | 78,398,000Source | 65,263,000Source | 161,683,000Source | 77,906,000Source | 230,750,000Source | 71,795,000Source | 55,676,000Source | 45,547,000Source |
| Liabilities and EquityUSD | 596,677,000Source | 92,194,000Source | 79,443,000Source | 522,597,000Source | 84,786,000Source | 75,462,000Source | 293,445,000Source | 83,856,000Source | 239,828,000Source | 78,065,000Source | 62,693,000Source | 50,672,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 27,216,000Source | 6,839,000Source | 8,577,000Source | 36,772,000Source | 6,364,000Source | 10,083,000Source | 35,667,000Source | 5,903,000Source | 6,313,000Source | 6,200,000Source | 6,857,000Source | 4,880,000Source |
| Operating Lease, Liability, CurrentUSD | — | 93,000Source | 88,000Source | 24,000Source | 92,000Source | 87,000Source | 47,000Source | 91,000Source | 70,000Source | 90,000Source | 85,000Source | 80,000Source |
| Accounts Payable, CurrentUSD | 200,000Source | 545,000Source | 300,000Source | 156,000Source | 227,000Source | 509,000Source | 590,000Source | 410,000Source | 140,000Source | 402,000Source | 835,000Source | 443,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | 93,000Source | — | 24,000Source | 116,000Source | — | 47,000Source | — | 70,000Source | 160,000Source | 245,000Source |
| Deferred Income Tax Liabilities, NetUSD | 13,294,000Source | — | — | 6,161,000Source | — | — | — | — | 2,765,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | — | — | 93,000Source | — | 24,000Source | 116,000Source | — | 47,000Source | — | 70,000Source | 160,000Source | 245,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 6,365,000Source | 5,258,000Source | 6,998,000Source | 6,013,000Source | 5,086,000Source | 8,243,000Source | 4,397,000Source | 4,305,000Source | 5,173,000Source | 4,502,000Source | 4,748,000Source | 3,436,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 2,765,000Source | — | — | — |
| Short-term InvestmentsUSD | — | — | 18,530,000Source | — | — | 12,330,000Source | — | — | — | — | 20,073,000Source | — |
cash flow · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -64,702,000Source | 6,073,000Source | 40,899,000Source | 20,583,000Source | 14,325,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,483,000Source | 27,000Source | 862,000Source | 944,000Source | 741,000Source | 749,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,306,000Source | -66,000Source | -1,844,000Source | 2,508,000Source | 367,000Source | 874,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 12,000Source | -37,000Source | -88,000Source | -24,000Source | -81,000Source | 1,412,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 451,000Source | 8,000Source | -262,000Source | -433,000Source | 392,000Source | -234,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -10,284,000Source | -136,000Source | 5,727,000Source | -664,000Source | -351,000Source | 408,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,906,000Source | 5,624,000Source | 24,410,000Source | 21,330,000Source | 17,463,000Source | 16,056,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -87,310,000Source | -81,000Source | -189,982,000Source | 18,396,000Source | -26,835,000Source | -825,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 4,000Source | 51,000Source | 345,000Source | 476,000Source | 318,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | 45,000Source | 874,000Source | 3,510,000Source | 114,000Source | 45,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 4,991,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 90,135,000Source | 11,000Source | 117,192,000Source | -5,408,000Source | -4,937,000Source | 13,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 919,000Source | 5,554,000Source | -48,380,000Source | 34,318,000Source | -14,309,000Source | 15,244,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 10,311,000Source | 6,701,000Source | 13,616,000Source | 7,464,000Source | 9,871,000Source | 62,886,000Source | 8,952,000Source | 57,332,000Source | 23,014,000Source | 37,323,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 2,016,000Source | 204,000Source | 1,895,000Source | 268,000Source | 1,483,000Source | 27,000Source | 862,000Source | 944,000Source | 741,000Source | 749,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | — | — | — | — | — | — | 0Source | 309,000Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 8,013,000Source | 3,129,000Source | 5,140,000Source | 2,964,000Source | 4,893,000Source | 2,867,000Source | 12,732,000Source | 14,290,000Source | 12,737,000Source | 9,235,000Source |
| Income Tax Expense (Benefit)USD | — | — | 6,901,000Source | 766,000Source | 13,630,000Source | 1,126,000Source | -10,167,000Source | 1,724,000Source | 6,985,000Source | 3,517,000Source | 3,367,000Source | 2,233,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | — | — | — | 1,202,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 16,902,000Source | 5,609,000Source | 66,933,000Source | 11,000Source | -64,702,000Source | 6,073,000Source | 40,899,000Source | 20,583,000Source | 14,325,000Source | 17,222,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 16,902,000Source | 5,609,000Source | 66,933,000Source | 11,000Source | -64,702,000Source | 6,073,000Source | 40,899,000Source | 20,583,000Source | 14,325,000Source | 17,222,000Source |
| Nonoperating Income (Expense)USD | — | — | 29,193,000Source | 1,310,000Source | 82,616,000Source | -4,213,000Source | -43,768,000Source | 821,000Source | 26,951,000Source | 1,844,000Source | 489,000Source | 10,000Source |
| Operating Costs and ExpensesUSD | — | — | — | 1,186,000Source | — | 1,440,000Source | — | 1,138,000Source | — | 5,773,000Source | 4,809,000Source | 3,780,000Source |
| Operating Lease, Lease IncomeUSD | — | — | 6,264,000Source | 6,780,000Source | 6,095,000Source | 6,774,000Source | 6,217,000Source | 7,079,000Source | 27,488,000Source | 37,262,000Source | 34,039,000Source | 30,561,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | 5,000Source | — | — | 4,000Source | 2,000Source | 13,000Source | 17,000Source | -5,000Source | — |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | — | — | — | 1,949,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 2,187,000Source | — | 119,602,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 56,000Source | 1,464,000Source | 51,000Source | 168,000Source | 58,000Source |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | —Source | — | — | — | — | — |
| CryptoAssetRealizedGainLossNonoperating | — | — | —Source | — | —Source | — | —Source | — | — | — | — | — |
| LitigationSettlementLoss | — | — | — | — | — | — | —Source | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 7,491,000Source | 13,512,000Source | 8,217,000Source | 14,465,000Source | 8,835,000Source | 15,903,000Source | 56,294,000Source | 68,184,000Source | 56,686,000Source | 53,027,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Income (Loss)USD | — | — | -5,390,000Source | 5,065,000Source | -2,053,000Source | 5,350,000Source | -31,101,000Source | 6,976,000Source | 20,933,000Source | 22,256,000Source | 17,203,000Source | 19,445,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | 5,000Source | — | — | 4,000Source | 2,000Source | 13,000Source | 17,000Source | -5,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 23,803,000Source | 6,375,000Source | 80,563,000Source | 1,137,000Source | -74,869,000Source | 7,797,000Source | 47,884,000Source | 24,100,000Source | 17,692,000Source | 19,455,000Source |
| Income Tax Expense (Benefit)USD | — | — | 6,901,000Source | 766,000Source | 13,630,000Source | 1,126,000Source | -10,167,000Source | 1,724,000Source | 6,985,000Source | 3,517,000Source | 3,367,000Source | 2,233,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 16,902,000Source | 5,609,000Source | 66,933,000Source | 11,000Source | -64,702,000Source | 6,073,000Source | 40,899,000Source | 20,583,000Source | 14,325,000Source | 17,222,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 1.14Source | 0.8Source | 5.71Source | 0Source | -6.74Source | 0.88Source | 5.66Source | 3.06Source | 2.13Source | 2.56Source |
| Earnings Per Share, DilutedUSD per share | — | — | 1.07Source | 0.72Source | 5.04Source | 0Source | -6.74Source | 0.78Source | 5.13Source | 2.63Source | 1.79Source | 2.12Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 14,848,408Source | 7,045,108Source | 11,727,660Source | 6,944,664Source | 9,596,037Source | 6,892,742Source | 7,228,961Source | 6,732,806Source | 6,726,687Source | 6,731,693Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 16,545,198Source | 7,771,088Source | 13,484,746Source | 7,795,149Source | 9,596,037Source | 7,782,393Source | 7,980,118Source | 7,819,159Source | 7,999,750Source | 8,138,608Source |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | 12,881,000Source | 8,447,000Source | 10,270,000Source | 9,115,000Source | 39,936,000Source | 8,927,000Source | 35,361,000Source | 45,928,000Source | 39,483,000Source | 33,582,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 1,258,000Source | 4,181,000Source | 3,718,000Source | 1,825,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 120,000Source | 176,000Source | 579,000Source | 599,000Source | 589,000Source | 628,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | — | — | — | — | — | — | 0Source | 309,000Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 8,013,000Source | 3,129,000Source | 5,140,000Source | 2,964,000Source | 4,893,000Source | 2,867,000Source | 12,732,000Source | 14,290,000Source | 12,737,000Source | 9,235,000Source |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | 494,000Source | 10,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | 16,902,000Source | 5,609,000Source | 66,933,000Source | 11,000Source | -64,702,000Source | 6,073,000Source | 40,899,000Source | 20,583,000Source | 14,325,000Source | 17,222,000Source |
| Nonoperating Income (Expense)USD | — | — | 29,193,000Source | 1,310,000Source | 82,616,000Source | -4,213,000Source | -43,768,000Source | 821,000Source | 26,951,000Source | 1,844,000Source | 489,000Source | 10,000Source |
| Operating Costs and ExpensesUSD | — | — | — | 1,186,000Source | — | 1,440,000Source | — | 1,138,000Source | — | 5,773,000Source | 4,809,000Source | 3,780,000Source |
| Operating Lease, Lease IncomeUSD | — | — | 6,264,000Source | 6,780,000Source | 6,095,000Source | 6,774,000Source | 6,217,000Source | 7,079,000Source | 27,488,000Source | 37,262,000Source | 34,039,000Source | 30,561,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | 4,792,000Source | 5,421,000Source | — | — |
| Selling and Marketing ExpenseUSD | — | — | 3,121,000Source | 2,976,000Source | 3,154,000Source | 3,456,000Source | 3,041,000Source | 3,675,000Source | 13,078,000Source | 18,147,000Source | 17,685,000Source | 14,445,000Source |
| CryptoAssetRealizedGainLossNonoperating | — | — | —Source | — | —Source | — | —Source | — | — | — | — | — |
| Interest Income (Expense), Nonoperating, Net | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| LitigationSettlementLoss | — | — | — | — | — | — | —Source | — | — | — | — | — |
Offerings
Registration 333-280013
Registration 333-286559
Filing attachments
tm263118d3_ex4-1.htm · 8-K · 2026-01-16
Exhibit 4.1 EXECUTION VERSION SEMLER SCIENTIFIC, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of January 16, 2026 4.25% Convertible Senior Notes due 2030 FIRST SUPPLEMENTAL INDENTURE, dated as of January 16, 2026 (this “Supplemental Indenture”), between Semler Scientific, Inc., a Delaware corporation (the “Company”), as issuer, and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to the Indenture, date…
Read attachment ↗